share_log

Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) Surges 5.1%; Individual Investors Who Own 50% Shares Profited Along With Institutions

Simply Wall St ·  Dec 3 10:50

Key Insights

  • Inner Mongolia Furui Medical Science's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • 47% of the business is held by the top 25 shareholders
  • 17% of Inner Mongolia Furui Medical Science is held by insiders

To get a sense of who is truly in control of Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 50% to be precise, is individual investors. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Individual investors gained the most after market cap touched CN¥10b last week, while institutions who own 27% also benefitted.

Let's delve deeper into each type of owner of Inner Mongolia Furui Medical Science, beginning with the chart below.

big
SZSE:300049 Ownership Breakdown December 3rd 2024

What Does The Institutional Ownership Tell Us About Inner Mongolia Furui Medical Science?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Inner Mongolia Furui Medical Science already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Inner Mongolia Furui Medical Science, (below). Of course, keep in mind that there are other factors to consider, too.

big
SZSE:300049 Earnings and Revenue Growth December 3rd 2024

Hedge funds don't have many shares in Inner Mongolia Furui Medical Science. With a 11% stake, CEO Guanyi Wang is the largest shareholder. Meanwhile, the second and third largest shareholders, hold 6.0% and 3.8%, of the shares outstanding, respectively.

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Inner Mongolia Furui Medical Science

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our information suggests that insiders maintain a significant holding in Inner Mongolia Furui Medical Science Co., Ltd.. It has a market capitalization of just CN¥10b, and insiders have CN¥1.8b worth of shares in their own names. That's quite significant. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

General Public Ownership

The general public, who are usually individual investors, hold a 50% stake in Inner Mongolia Furui Medical Science. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Company Ownership

We can see that Private Companies own 6.0%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. To that end, you should be aware of the 1 warning sign we've spotted with Inner Mongolia Furui Medical Science .

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment